PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30174606 ↗2018Reported benefit

Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling.

MouseChemical/toxinWild-type C57BL/6 and Nrf2 knockout on C57BL backgroundMalen = 5 mice per group

Model: Severe acute pancreatitis induced by seven hourly intraperitoneal injections of cerulein 50 microgram/kg in 0.9 per cent sodium chloride, with lipopolysaccharide 10 mg/kg added to the last cerulein injection

Isoliquiritigenin reduced pancreatic and intestinal histological injury and cleaved caspase-3, lowered IL-6, TNF-alpha and malondialdehyde, raised superoxide dismutase, Nrf2, HO-1 and NQO-1, reduced NF-kB and restored IkB, and increased the intestinal junction proteins P120-catenin and occludin. Nr…

Extraction: extract · Supplied extraction confidence: 0.82. Machine-extracted fields require source verification.